Latest News

schizophrenia
New Baseline Data on Iclepertin for Schizophrenia

June 18th 2024

Check out the latest results from the phase 3 CONNEX-X study.

Investigational agent KarXT is a first-in-class muscarinic receptor agonist demonstrating antipsychotic efficacy and safety in short- and long-term clinical trials.
Investigational Antipsychotic Demonstrates Efficacy Without Blocking Dopamine Receptor

June 7th 2024

What is new in research on schizophrenia?
Schizophrenia Research Roundup: June 7, 2024

June 7th 2024

Experts shared the study results in a poster presentation at the 2024 ASCP Annual Meeting.
Phase 1 Study Findings Support Efficacy of ALTO-101 for the Treatment of Cognitive Impairment in Schizophrenia

June 6th 2024

Video Series
Video Interviews
Podcasts
schizophrenia evolution psychiatry
Latest CME Events & Activities

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

PER® Psychiatry Summit

November 7, 2024

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Real Psychiatry 2025

January 17 - 18, 2025

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

More News

© 2024 MJH Life Sciences

All rights reserved.